hypericin has been researched along with dactinomycin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Agostinis, P; de Witte, P; Hendrickx, N; Moens, U; Piette, J; Seternes, OM; Vandenheede, JR; Volanti, C | 1 |
2 other study(ies) available for hypericin and dactinomycin
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells.
Topics: Anthracenes; Apoptosis; Blotting, Western; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Dactinomycin; Dinoprostone; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; HeLa Cells; Humans; Imidazoles; Isoenzymes; Membrane Proteins; Mitogen-Activated Protein Kinases; Mutation; NF-kappa B; Nitrobenzenes; p38 Mitogen-Activated Protein Kinases; Perylene; Photochemotherapy; Precipitin Tests; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Signal Transduction; Sulfonamides; Time Factors; Transcription, Genetic; Transfection; Up-Regulation | 2003 |